Entering text into the input field will update the search result below

Premarket Gainers as of 9:05 am (9/4/2018)

  • NASDAQ:MNKD +47% on collaborating with United Therapeutics for pulmonary hypertension products.
  • TA +36% on announcing sale of Minit Mart for ~$330.8M to EG Group.
  • REPH +25% on planned resubmission of IV meloxicam NDA.
  • CREG +20% on acquiring 20% Ownership of Xi’an Xinhuan.
  • CRIS +11%.
  • CHEK +9% on announcing interim results from its ongoing post-CE approval study of C-Scan system Version 3.
  • CRON +9% on announcing partnership with Ginkgo Bioworks to produce cultured cannabinoids.
  • NBEV +8%.
  • SESN +8%.
  • GERN +7%.
  • CONN +7% on Q2 earnings.
  • SENS +6%.
  • RIGL +6%.
  • BLDP +5% after signing agreement to divest non-core Power Manager business.
  • CANF +5% after providing update on its Phase II clinical trial of Namodenoson (CF102) for the treatment of advanced HCC.
  • PCG +5% after analysts upgrade.

Recommended For You

About MNKD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MNKD--
MannKind Corporation